Logo: University of Southern California

Events Calendar


  • BME 533 - Seminar in Biomedical Engineering

    Mon, Jan 31, 2011 @ 12:30 PM - 01:50 PM

    Alfred E. Mann Department of Biomedical Engineering

    Conferences, Lectures, & Seminars


    Speaker: Dr. George Truskey, Duke University

    Talk Title: Engineering Endothelial Progenitor Cells for Vascular Repair

    Series: Invited Chair Series

    Abstract: Endothelial progenitor cells can be obtained from cord blood, adult blood or bone marrow and serve as a potential source of vascular endothelium for a variety of therapeutic applications. Our own work has focused upon using late outgrowth endothelial progenitor cells for a variety of applications including seeding vascular devices, preparing, tissue engineered blood vessels and repair of endothelial injury. The focus of this talk is upon the use of human endothelial cells derived from late outgrowth cord bold (hCB-ECs) to accelerate vein graft re-endothelialization, and reduce vein graft atherosclerosis.

    As a principal cause of vein graft failure, endothelial injury complicates ~500,000 vein graft procedures performed annually in the US to treat atherosclerosis. Over-distension of the vein graft by arterial pressure leads to endothelial injury, which exposes the extracellular matrix to circulating blood and promotes vein graft thrombosis. Neointimal hyperplasia subsequently predisposes vein grafts to accelerated atherosclerosis, and late vein graft failure. The hCB-ECs function similarly to vascular endothelium. The hCB-ECs demonstrate smaller size, superior adhesive properties and higher 51 integrin expression levels compared with EC adhesion to SMC/extracellular matrix is significantly greater under flow conditions with hCB-ECs than with ECs derived from adult human peripheral blood EPCs. When administered intravenously, hCB-ECs enhanced vein graft re-endothelialization, and prevented thrombosis in carotid interposition vein grafts implanted in SCID mice. To better understand the adhesion process, we examined adhesion of hCB-ECs as a function of shear stress in vitro. The number of adherent cells varied with shear stress, with the maximum number of adherent cells and the shear stress at maximum adhesion depending upon fluid viscosity. A dimensional analysis indicated that adhesion was a function of the net force on the cells, the ratio of cell diffusion to sliding speed and molecular diffusivity. This work suggests that delivery conditions can be developed to maximize adhesion of EPCs for repair of damaged arteries.


    Host: Department of Biomedical Engineering, USC

    Location: Olin Hall of Engineering (OHE) - 122

    Audiences: Everyone Is Invited

    Contact: Mischalgrace Diasanta

    Add to Google CalendarDownload ICS File for OutlookDownload iCal File

Return to Calendar